Trial intelligence / Profile preview

Povidone Iodine vs Hypochlorous Acid for Neonatal Circumcision

NCT05175027Completed

Sponsor
Hisar Intercontinental Hospital
Start
May 2021
Primary completion
Oct 2021
Modality
DNA Intercalators/Alkylators
Countries
1
01

Overview

Randomised trial of hypochlorous acid in Infection, sponsored by Hisar Intercontinental Hospital. Primary endpoints: Wound healing at 1 month and Antibacterial effect at 1 week. Started May 2021; status: completed.

02

Drugs

hypochlorous acid
03

Conditions

Infection

Beyond the preview

Go deeper on NCT05175027.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05175027.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call